Univariate |
P-value |
OR |
95% CI |
Age (per year) |
<0.001 |
1.094 |
1.041 – 1.150 |
Gender male |
0.909 |
1.068 |
0.347 – 3.286 |
BMI |
0.941 |
1.005 |
0.885 – 1.141 |
Current smoker |
0.012 |
0.203 |
0.058 – 0.706 |
Diabetes |
0.024 |
3.392 |
1.177 – 9.770 |
Hypertension |
0.142 |
2.016 |
0.790 – 5.141 |
Hypercholesterolaemia |
0.083 |
2.302 |
0.896 – 5.915 |
Killip Class >1 |
0.121 |
2.458 |
0.789 – 7.652 |
Previous MI |
0.661 |
1.397 |
0.314 – 6.217 |
Previous PCI |
0.049 |
3.147 |
1.006 – 9.848 |
Systolic BP (per 10 mm Hg) |
0.262 |
0.891 |
0.728 – 1.090 |
Diastolic BP (per 10 mm Hg) |
0.256 |
0.832 |
0.606 – 1.143 |
Tirofiban study medication |
0.141 |
2.103 |
0.781 – 5.661 |
Culprit Vessel RCA* |
0.949 |
1.052 |
0.223 – 4.960 |
Culprit Vessel LAD* |
0.936 |
0.937 |
0.191 – 4.595 |
TIMI grade flow post PCI <3 |
0.681 |
0.653 |
0.085 – 4.987 |
NT-proBNP baseline (per 1000 increase) |
0.539 |
1.070 |
0.862 – 1.329 |
NT-proBNP 24 hr (per 1000 increase) |
<0.001 |
1.193 |
1.088 – 1.308 |
NT-proBNP 72 hr (per 1000 increase) |
<0.001 |
1.290 |
1.151 – 1.447 |
HScTnT (per 0.1 increase) |
0.513 |
0.970 |
0.884 – 1.063 |
Peak CK-MB (per 100 increase) |
0.014 |
1.230 |
1.044 – 1.450 |